Bmi-1 protein is significantly overexpressed in ovarian, endometrial, and cervical cancer [44], and Sasaki et al. [45] found that overexpression of Bmi-1 and EZH2 is associated with the malignant progression of hepatocellular carcinoma. This evidence concerns the gene EZH2 and cervical cancer.